RadNet, Inc. (NASDAQ:RDNT) Shares Sold by Great West Life Assurance Co. Can


Share on StockTwits

Great West Life Assurance Co. Can trimmed its holdings in RadNet, Inc. (NASDAQ:RDNT) by 6.2% during the third quarter, HoldingsChannel.com reports. The fund owned 46,361 shares of the medical research company’s stock after selling 3,065 shares during the period. Great West Life Assurance Co. Can’s holdings in RadNet were worth $711,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in RDNT. Private Advisor Group LLC acquired a new position in RadNet in the 2nd quarter valued at $48,000. Captrust Financial Advisors increased its stake in RadNet by 21.7% in the 3rd quarter. Captrust Financial Advisors now owns 11,375 shares of the medical research company’s stock valued at $174,000 after buying an additional 2,030 shares during the period. Louisiana State Employees Retirement System increased its stake in RadNet by 74.8% in the 3rd quarter. Louisiana State Employees Retirement System now owns 19,800 shares of the medical research company’s stock valued at $304,000 after buying an additional 8,470 shares during the period. Keybank National Association OH acquired a new position in RadNet in the 3rd quarter valued at $384,000. Finally, Pacer Advisors Inc. acquired a new position in RadNet in the 3rd quarter valued at $406,000. 67.33% of the stock is currently owned by institutional investors and hedge funds.

Several equities analysts have issued reports on the stock. BidaskClub raised shares of RadNet from a “hold” rating to a “buy” rating in a research note on Wednesday, December 30th. ValuEngine raised shares of RadNet from a “hold” rating to a “buy” rating in a research note on Wednesday, October 21st. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The company has an average rating of “Buy” and an average target price of $21.67.

NASDAQ:RDNT opened at $21.10 on Thursday. The company has a quick ratio of 0.65, a current ratio of 0.65 and a debt-to-equity ratio of 2.73. RadNet, Inc. has a fifty-two week low of $5.81 and a fifty-two week high of $23.45. The stock has a market cap of $1.09 billion, a PE ratio of -78.15 and a beta of 1.46. The firm’s fifty day simple moving average is $19.18 and its 200-day simple moving average is $16.88.

RadNet (NASDAQ:RDNT) last released its quarterly earnings data on Monday, November 9th. The medical research company reported $0.15 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.21. RadNet had a negative net margin of 1.25% and a negative return on equity of 4.28%. The business had revenue of $291.80 million for the quarter, compared to analyst estimates of $254.68 million. During the same period in the previous year, the firm earned $0.08 EPS. The business’s revenue for the quarter was down .3% compared to the same quarter last year. Equities analysts anticipate that RadNet, Inc. will post -0.38 earnings per share for the current year.

In related news, insider Norman R. Hames sold 15,000 shares of the business’s stock in a transaction dated Thursday, December 3rd. The shares were sold at an average price of $18.95, for a total value of $284,250.00. Following the sale, the insider now directly owns 477,067 shares in the company, valued at approximately $9,040,419.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Norman R. Hames sold 10,000 shares of the business’s stock in a transaction dated Tuesday, December 1st. The stock was sold at an average price of $18.95, for a total transaction of $189,500.00. Following the completion of the sale, the insider now owns 497,067 shares in the company, valued at $9,419,419.65. The disclosure for this sale can be found here. Insiders sold a total of 85,000 shares of company stock worth $1,609,600 over the last quarter. Insiders own 5.77% of the company’s stock.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.

Read More: Short Selling Stocks, A Beginner’s Guide

Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RadNet, Inc. (NASDAQ:RDNT).

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.